{"slug":"wuxi-apptec","name":"우시앱텍(약명강덕)","name_en":"WuXi AppTec","ticker":"2359.HK","updated_at":"2026-07-11T10:21:36.35+00:00","canonical":"https://valuechain.wiki/wuxi-apptec","kicker":"항셍 지수","kicker_en":"Hang Seng Index","lead":"세계적 신약개발 위탁연구·생산(CRO/CDMO) 기업으로 글로벌 제약사에 화학 합성과 개발 서비스를 제공한다. 항셍 지수 구성종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A global CRO/CDMO providing chemistry, drug discovery, and development services to pharmaceutical companies worldwide. Hang Seng Index constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"화학사업(WuXi Chemistry)"},{"name":"테스트"},{"name":"바이올로직스·세포유전자"}],"total":"약 ¥403억 (FY2023)"},"segments_en":{"parts":[{"name":"WuXi Chemistry"},{"name":"Testing"},{"name":"Biologics & cell/gene therapy"}],"total":"approx. CN¥40.3B (FY2023)"},"returns_yearly":{"2021":-27.8,"2022":-8,"2023":-46,"2024":5.1,"2025":104.4,"2026":41.3},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}